Urquhart, John - In: PharmacoEconomics 15 (1999) 3, pp. 217-228
, cholestyramine and gemfibrozil, in which exceptionally careful measurements of compliance were made, which has not been done in later …-effect relation for cholestyramine is linear, making compliance-neutral the cost to prevent 1 coronary event, provided that refills …